Inicio/Acciones/NRXS

NRXS

USD

Neuraxis Inc. Common Stock

$2.540-0.120 (-4.511%)

Precio en Tiempo Real

Healthcare

Biotecnología

Estados Unidos

Gráfico de Precios

Loading Chart...

Métricas Clave

Métricas de Mercado

Fundamentos de la Empresa

Estadísticas de Negociación

Métricas de Mercado

Apertura

$2.660

Máximo

$2.630

Mínimo

$2.520

Volumen

0.12M

Fundamentos de la Empresa

Capitalización de Mercado

25.4M

Industria

Biotecnología

País

United States

Estadísticas de Negociación

Volumen Promedio

0.38M

Bolsa

ASE

Moneda

USD

Rango de 52 Semanas

Mínimo $1.33Actual $2.540Máximo $6.2

Noticias Relacionadas

4 nov 2025 · 13:30

GlobeNewswire

NeurAxis to Host Third Quarter 2025 Results and Business Update Call on Tuesday, November 11, 2025

CARMEL, Ind., Nov. 04, 2025 (GLOBE NEWSWIRE) -- NeurAxis, Inc. ("NeurAxis," or the "Company") (NYSE:NRXS), a medical technology company commercializing neuromodulation therapies addressing chronic and debilitating

NeurAxis to Host Third Quarter 2025 Results and Business Update Call on Tuesday, November 11, 2025

24 oct 2025 · 12:00

GlobeNewswire

NeurAxis Awarded First Ever FDA Clearance for the Treatment of Pain in Functional Dyspepsia (FD) with associated Nausea Symptoms in the Adult Patient Population

Achieves significant expansion of NeurAxis' total addressable marketClearance now includes patients aged "8 years and older"Expanded age indication will utilize the upcoming January 1st, 2026, Category I CPT code to